Skip to Main Navigation Skip to Page Content

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

p-Anisidine hydrochloride: Target Organs and Levels of Evidence for TR-116

Bioassay of p-Anisidine Hydrochloride for Possible Carcinogenicity (CASRN 20265-97-8)

Chemical (Study Title) CASRN	Peer Review Date	Route/Exposure Levels	Study Laboratory
p-Anisidine hydrochloride 20265-97-8	04/26/1978	Dosed-Feed R: 0,.3,.6, M: 0,.5,1.0 %/55 PER GROUP	T.S.I. Mason Laboratories, Inc.

Levels of Evidence

Male Rats: Equivocal

Type	Organ/Tissue (Lesion)
Neoplastic Lesions	Preputial Gland: (ADENOMA OR CARCINOMA)

p-Anisidine hydrochloride: Target Organs and Levels of Evidence for TR-116

Bioassay of p-Anisidine Hydrochloride for Possible Carcinogenicity (CASRN 20265-97-8)

Levels of Evidence

Male Rats: Equivocal

Female Rats: Negative

Male Mice: Negative

Female Mice: Negative